Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Sep 21 - Sep 26
A de novo mutation in the adenosine triphosphatase (ATPase) 8 gene in a patient with mitochondrial disorder
Animal (2020) 14:S4454
The Future of Oral Peptide Drugs Heinis's team is now working on oral peptides for gastrointestinal diseases , including: Crohns disease Ulcerative colitis Bacterial infections Their first major success involves generating enzyme-resistant peptides targeting the interleukin-23 receptor , a key factor in inflammatory bowel disease (IBD)
Risk of additional cancers in untreated and treated hairy cell leukemia patients
Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides
Matoba K, Dohi E, Choi EY, Kano SI (2023) Glutathione S-transferases control astrocyte activation and neuronal health during neuroinflammation
US$ 28.64
US$ 20.50
US$ 24.42
